Impact of Brahmi Churna and Heartfulness Meditation as an Adjunct on Psychological Attributes and Cardiovascular Risk in Essential Hypertension
DOI:
https://doi.org/10.47070/ayushdhara.v13i2.2584Keywords:
Bacopa monnieri, Brahmi, Hypertension, Cardiovascular Risk, Anxiety, Integrative AyurvedaAbstract
Hypertension is a major risk factor for cardiovascular disease and is frequently associated with comorbid conditions such as hypothyroidism and psychological distress, including anxiety, sleep disturbances, and reduced quality of life. Psychological stress further contributes to cardiovascular risk through autonomic and metabolic mechanisms. Integrative approaches including Ayurvedic Medhya Rasayana and meditation may help address both psychological and cardiovascular risk factors. Case Description: A 42-year-old hypertensive female with hypothyroidism presented with uneasiness, palpitations, and disturbed sleep. She was on Lodoz 2.5mg and Thyronorm 50mcg. The patient was administered Bacopa monnieri (Brahmi) churna 3g twice daily for 45 days along with lifestyle modification and Heartfulness meditation. Assessments: Psychological parameters were assessed using POMS, MHC-SF, HARS, SPANE, Flourishing Scale, and WHOQOL-BREF. Cardiovascular risk assessment included blood pressure, lipid profile, and Framingham Risk Score. Results: Marked improvement was observed in anxiety, mood, mental well-being, and quality of life scores. Lipid profile and blood pressure improved, and Framingham Risk Score reduced from 4.68% to 3.95%, indicating reduced cardiovascular risk. No adverse events were reported. Conclusion: Bacopa monnieri as an adjunct to standard therapy, along with lifestyle modification and meditation, may improve psychological well-being and reduce cardiovascular risk in hypertensive patients. Further clinical studies are required to confirm these findings.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2026 AYUSHDHARA

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
